MiNK Therapeutics
INKT
INKT
24 hedge funds and large institutions have $632K invested in MiNK Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$10.1K | |
| 2 | +$9.17K | |
| 3 | +$2.54K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.38K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$882 |
Top Sellers
| 1 | -$17.9K | |
| 2 | -$17.3K | |
| 3 | -$16.7K | |
| 4 |
Millennium Management
New York
|
-$12.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.17K |